Литература / Клин+рекомендации+ACG-2020+по+хр+панкреатиту.+Кучерявыйs

•-

1.. ., . . ‹

. 2017. . 89. - 2. •. 105–113.

5.Löhr J.M., Dominguez-Munoz E., Rosendahl J. et al. HaPanEU/UEG Working Group. United European Gastroenterology evidencebased guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) // United European Gastroenterol. J. 2017. Vol. 5.

-2. P. 153–199.

6.Whitcomb D.C., Shimosegawa T., Chari S.T. et al. International consensus statements on early chronic pancreatitis: recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, American Pancreatic Association, Japan Pancreas Society, PancreasFest Working Group and European Pancreatic Club // Pancreatology. 2018. S1424–3903(18)30113–3.

7.Gardner T.B., Adler D.G., Forsmark C.E. et al. ACG Clinical Guideline: Chronic Pancreatitis // Am. J. Gastroenterol. 2020. Vol. 115.

-3. P. 322–339.

8.Whitcomb D.C.; the North American Pancreas Study Group. Pancreatitis: TIGAR-O version 2 risk/etiology checklist with topic reviews, updates, and use primers // Clin. Transl. Gastroenterol. 2019. Vol. 10. - 6. P. e00027.

9.Schneider A., Lohr J.M., Singer M.V. The MANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease // J. Gastroenterol. 2007. Vol. 42. - 2. P. 101–119.

10.Shimosegawa T., Chari S.T., Frulloni L. et al. International consensus diagnostic criteria for autoimmune pancreatitis: Guidelines of the International Association of Pancreatology // Pancreas. 2011. Vol. 40. - 3. P. 352–358.

11..”., . . IgG4- …. • . ., 2014.

12.. ., .•., † ‘.•. € . †

// „ , . 2012. - 4. •. 3–10.

13. • . ., … ‡ ‚ .“., • • Ž. . € . “ • // ‘

. 2018. . 13. - 3. •. 29–40.

14.Yadav D., O’Connell M., Papachristou G.I. Natural history following the first attack of acute pancreatitis // Am. J. Gastroenterol. 2012. Vol. 107. - 7. P. 1096–1103.

15.Ammann R.W., Buehler H., Muench R. et al. Differences in the natural history of idiopathic (nonalcoholic) and alcoholic chronic pancreatitis: a comparative long-term study of 287 patients // Pancreas. 1987. Vol. 2. - 4. P. 368–377.

16.Mullady D.K., Yadav D., Amann S.T. et al. Type of pain, pain-associated complications, quality of life, disability and resource utilization in chronic pancreatitis: a prospective cohort study // Gut. 2011. Vol. 60. - 1. P. 77–84.

17.Ammann R.W., Akovbiantz A., Largiarder F. et al. Course and outcome of chronic pancreatitis: longitudinal study of a mixed medicalsurgical series of 245 patients // Gastroenterology. 1984. Vol. 86. - 5. Pt. 1. P. 820–828.

Лекции для врачей

18.Lankisch P.G., Löhr-Happe A., Otto J., Creutzfeldt W. Natural course in chronic pancreatitis: pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease // Digestion. 1993. Vol. 54. - 3. P. 148–155.

19.Shelton C.A., Umapathy C., Stello K. et al. Hereditary pancreatitis in the United States: Survival and rates of pancreatic cancer // Am. J. Gastroenterol. 2018. Vol. 113. - 9. P. 1376–1384.

20.Malka D., Hammel P., Sauvanet A. et al. Risk factors for diabetes mellitus in chronic pancreatitis // Gastroenterology. 2000. Vol. 119.

-5. P. 1324–1332.

21.Bellin M.D., Whitcomb D.C., Abberbock J. et al. Patient and disease characteristics associated with the presence of diabetes mellitus in adults with chronic pancreatitis in the United States // Am. J. Gastroenterol. 2017. Vol. 112. - 9. P. 1457–1465.

22.Rebours V., Boutron-Ruault M.C., Schnee M. et al. The natural history of hereditary pancreatitis: a national series // Gut. 2009. Vol. 58.

-1. P. 97–103.

23.Tolstrup J.S., Kristiansen L., Becker U. et al. Smoking and risk of acute and chronic pancreatitis among women and men: a populationbased cohort study // Arch. Intern. Med. 2009. Vol. 169. - 6. P. 603–609.

24.Issa Y., Kempeneers M.A., van Santvoort H.C. et al. Diagnostic performance of imaging modalities in chronic pancreatitis: a systematic review and meta-analysis // Eur. Radiol. 2017. Vol. 27. - 9. P. 3820–3844.

25.Hoffmeister A., Mayerle J., Beglinger C. et al. English language version of the S3-consensus guidelines on chronic pancreatitis: definition, etiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis // Z. Gastroenterol. 2015. Vol. 53. - 12. P. 1447–1495.

26.Catalano M.F., Sahai A., Levy M. et al. EUS-based criteria for the diagnosis of chronic pancreatitis: The Rosemont classification // Gastrointest. Endosc. 2009. Vol. 69. - 7. P. 1251–1261.

27.Albashir S., Bronner M.P., Parsi M.A. et al. Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: correlation in chronic pancreatitis // Am. J. Gastroenterol. 2010. Vol. 105. - 11. P. 2498–2503.

28.Shmulewitz A., Teefey S.A., Robinson B.S. Factors affecting image quality and diagnostic efficacy in abdominal sonography: a prospective study of 140 patients // J. Clin. Ultrasound. 1993. Vol. 21. - 9. P. 623–630.

29.Strobel D., Bernatik T., Blank W. et al. Incidence of bleeding in 8172 percutaneous ultrasound-guided intraabdominal diagnostic and therapeutic interventions – results of the prospective multicenter DEGUM interventional ultrasound study (PIUS study) // Ultraschall Med. 2015. Vol. 36. - 2. P. 122–131.

30.Postema M., Gilja O.H. Contrast-enhanced and targeted ultrasound // World J. Gastroenterol. 2011. Vol. 17. - 1. P. 28–41.

31.D’Onofrio M., Zamboni G., Tognolini A. et al. Mass-forming pancreatitis: value of contrast-enhanced ultrasonography // World J. Gastroenterol. 2006. Vol. 12. - 26. P. 4181–4184.

32.Hellerhoff K.J., Helmberger H., Rosch T. et al. Dynamic MR pancreatography after secretin administration: image quality and diagnostic accuracy // Am. J. Roentgenol. 2002. Vol. 179. - 1. P. 121–129.

33.Madzak A., Olesen S.S., Wathle G.K. et al. Secretin-stimulated magnetic resonance imaging assessment of the benign pancreatic disorders: systematic review and proposal for a standardized protocol // Pancreas. 2016. Vol. 45. - 8. P. 1092–1103.

34.Manfredi R., Lucidi V., Gui B. et al. Idiopathic chronic pancreatitis in children: MR cholangiopancreatography after secretin administration // Radiology. 2002. Vol. 224. - 3. P. 675–682.

35.Cappeliez O., Delhaye M., Deviere J. et al. Chronic pancreatitis: evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation // Radiology. 2000. Vol. 215. - 2. P. 358–364.

36.Frulloni L., Falconi M., Gabbrielli A. et al. Italian consensus guidelines for chronic pancreatitis // Dig. Liver Dis. 2010. Vol. 42. Suppl. 6. P. S381–S406.

37.Haas S.L., Krins S., Knauerhase A.,€Löhr M. Altered bone metabolism and bone density in patients with chronic pancreatitis and pancreatic exocrine insufficiency // J. Pancreas. 2015. Vol. 16. - 1. P. 58–62.

38.Dominguez Munoz J.E., Iglesias-Garcia J., Vilarino-Insua M., Iglesias-Reyet M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis // Clin. Gastroenterol. Hepatol. 2007. Vol. 5. - 4. P. 484–488.

39.Stevens T., Parsi M.A. Update on endoscopic pancreatic function testing // World J. Gastroenterol. 2011. Vol. 17. - 35. P. 3957–3961.

40.Vanga R.R., Tansel A., Sidiq S. et al. Diagnostic performance of measurement of fecal elastase-1 in detection of exocrine pancreatic insufficiency: systematic review and meta-analysis // Clin. Gastroenterol. Hepatol. 2018. Vol. 16. - 8. P. 1220–1228.

41..•., . ., . . † : • // ™ . 2010. - 12. •. 24–31.

42.Keller J., Meier V., Wolfram K.U. et al. Sensitivity and specificity of an abbreviated (13)C-mixed triglyceride breath test for measurement of pancreatic exocrine function // United European Gastroenterol. J. 2014. Vol. 2. - 4. P. 288–294.

43.Shafiq N., Rana S., Bhasin D. et al. Pancreatic enzymes for chronic pancreatitis // Cochrane Database Syst. Rev. 2009. Vol. 4. CD006302.

44.Duggan S.N., Smyth N.D., O’Sullivan M. et al. The prevalence of malnutrition and fat-soluble vitamin deficiencies in chronic pancreatitis // Nutr. Clin. Pract. 2014. Vol. 29. - 3. P. 348–354.

45.Girish B.N., Rajesh G., Vaidyanathan K., Balakrishnan V. Zinc status in chronic pancreatitis and its relationship with exocrine and endocrine insufficiency // J. Pancreas. 2009. Vol. 10. - 6. P. 651–656.

46.Tignor A.S., Wu B.U., Whitlock T.L. et al. High prevalence of low-trauma fracture in chronic pancreatitis // Am. J. Gastroenterol. 2010. Vol. 105. - 12. P. 2680–2686.

47.Duggan S.N., Purcell C., Kilbane M. et al. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study // Am. J. Gastroenterol. 2015. Vol. 110. - 2. P. 336–345.

48.Sikkens E.C., Cahen D.L., Koch A.D. et al. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis // Pancreatology. 2013. Vol. 13. - 3. P. 238–242.

Лекции для врачей

49.Reddy S.V., Ramesh V., Bhatia E. Double blind randomized control study of intramuscular vitamin D3 supplementation in tropical calcific pancreatitis // Calcif. Tissue Int. 2013. Vol. 93. - 1. P. 48–54.

52.Kucheryavyy Yu.A., Andreev D.N. Nutritional status in patients with chronic pancreatitis // J. Nutritional Therapeutics. 2014. Vol. 3. - 3. P. 122–132.

53.Lindkvist B., Dominguez-Munoz J.E., Luaces-Regueira M. et al. Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis // Pancreatology. 2012. Vol. 12. - 4. P. 305–310.

54.Strum W.B. Abstinence in alcoholic chronic pancreatitis: effect on pain and outcome // J. Clin. Gastroenterol. 1995. Vol. 20.

-1. P. 37–41.

55.Yadav D., Whitcomb D.C. The role of alcohol and smoking in pancreatitis // Nat. Rev. Gastroenterol. Hepatol. 2010. Vol. 7.

-3. P. 131–145.

56.Nordback I., Pelli H., Lappalainen-Lehto R. et al. The recurrence of acute alcohol-associated pancreatitis can be reduced: a randomized controlled trial // Gastroenterology. 2009. Vol. 136. - 3. P. 848–855.

57.Sankaran S.J., Xiao A.Y., Wu L.M. et al. Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis // Gastroenterology. 2015. Vol. 149. - 6. P. 1490–1500.

58.Cote G.A., Yadav D., Slivka A. et al. Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis // Clin. Gastroenterol. Hepatol. 2011. Vol. 9. - 3. P. 266–723.

59.Yaghoobi M., McNabb-Baltar J., Bijarchi R., Cotton P.B. Pancreatic enzyme supplements are not effective for relieving abdominal pain in patients with chronic pancreatitis: meta-analysis and systematic review of randomized controlled trials // Can. J. Gastroenterol. Hepatol. 2015.

60.Graham D.Y. An enteric-coated pancreatic enzyme preparation that works // Dig. Dis. Sci. 1979. Vol. 24. - 12. P. 906–909.

61.Dutta S.K., Rubin J., Harvey J. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency // Gastroenterology. 1983. Vol. 84. - 3. P. 476–482.

62.Lankisch P.G., Lembcke B., Göke B., Creutzfeldt W. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage? // Z. Gastroenterol. 1986. Vol. 24. - 12. P. 753–757.

63.Halgreen H., Pedersen N.T., Worning H. Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis // Scand. J. Gastroenterol. 1986. Vol. 21. - 1. P. 104–108.

64.Gouerou H., Dain M.P., Parrondo I. et al. Alipase versus nonentericcoated enzymes in pancreatic insufficiency: a French multicenter crossover comparative study // Int. J. Pancreatol. 1989. Vol. 5. Suppl. P. 45–50.

65.Jørgensen B.B., Pedersen N.T., Worning H. Monitoring the effect of substitution therapy in patients with exocrine pancreatic insufficiency // Scand. J. Gastroenterol. 1991. Vol. 26. - 3. P. 321–326.

66.Paris J.C. A multicentre double-blind placebo-controlled study of the effect of a pancreatic enzyme formulation (Panzytrat 25000) on impaired lipid digestion in adults with chronic pancreatitis // Drug Invest. 1993. Vol. 5. - 4. P. 229–237.

67.Delhaye M., Meuris S., Gohimont A.C. et al. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis //

Eur. J. Gastroenterol. Hepatol. 1996. Vol. 8. - 7. P. 699–703.

68.Opekun A.R., Sutton F.M., Graham D.Y. Lack of dose-response with pancrease MT for the treatment of exocrine pancreatic insufficiency in adults // Aliment. Pharmacol. Ther. 1997. Vol. 11. - 5. P. 981–986.

69.Halm U., Löser C., Löhr M. et al. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency // Aliment. Pharmacol. Ther. 1999. Vol. 13. - 7. P. 951–957.

70.O’Keefe S.J., Cariem A.K., Levy M. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis // J. Clin. Gastroenterol. 2001. Vol. 32. - 4. P. 319–323.

71.Domínguez-Muñoz J.E., Iglesias-García J., Iglesias-Rey M. et al. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study // Aliment. Pharmacol. Ther. 2005. Vol. 21. - 8. P. 993–1000.

72.Vecht J., Symersky T., Lamers C.B., Mascleeet A.M. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency // J. Clin. Gastroenterol. 2006. Vol. 40. - 8. P. 721–725.

73.Safdi M., Bekal P.K., Martin S. et al. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis // Pancreas. 2006. Vol. 33. - 2. P. 156–162.

74.Whitcomb D.C., Lehman G.A., Vasileva G. et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized trial // Am. J. Gastroenterol. 2010. Vol. 105. - 10. P. 2276–2286.

75.Toskes P.P., Secci A., Thieroff-Ekerdt R., ZENPEP Study Group. Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis // Pancreas. 2011. Vol. 40. - 3. P. 376–382.

Лекции для врачей

76.Thorat V., Reddy N., Bhatia S. et al. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis – a double-blind, placebo-controlled study // Aliment. Pharmacol. Ther. 2012. Vol. 36. - 5. P. 426–436.

77.De la Iglesia-Garcia D., Huang W., Szatmary P. et al. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis // Gut. 2017. Vol. 66. - 8. P. 1354–1355.

78.•.•., .•., . . € . ••• … … •

…

: … // . 2020. . 92. - 1. •. 30–35.

79.Gubergrits N., Malecka-Panas E., Lehman G.A. et al. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery // Aliment. Pharmacol. Ther. 2011. Vol. 33. - 10. P. 1152–1161.

80.Ramesh H., Reddy N., Bhatia S. et al. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis // Pancreatology. 2013. Vol. 13. - 2. P. 133–139.

81.D’Haese J.G., Ceyhan G.O., Demir I.E. et al. Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: a 1-year disease management study on symptom control and quality of life // Pancreas. 2014. Vol. 43. - 6. P. 834–841.

82. •.•., .‘., . ., .•. • D …

• … • // . 2019. - 3. •. 156–160.

83.De la Iglesia-Garcia D., Vallejo-Senra N., Iglesias-Garcia J. et al. Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis // J. Clin. Gastroenterol. 2018. Vol. 52. - 8. P. e63–72.

84.Somaraju U.R., Solis-Moya A. Pancreatic enzyme replacement therapy for people with cystic fibrosis // Cochrane Database Syst. Rev. 2014. Vol. 10. CD008227.

85.Lindkvist B., Phillips M.E., Dominguez-Munoz J.E. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: prevalence and diagnostic use // Pancreatology. 2015. Vol. 15. - 6. P. 589–397.

86..•., . . ” … • //

„ , . 2005. - 5. •. 19–28.

87.. ., ” •. . • … // ‡

„ , , . 2010. . 20. - 5. •. 63–68.

88. . ., ” • .•., • •.•., . . ‘ …

€ // • … „ . 2012. - 7.

•. 43–47.

89.Domínguez-Muñoz J.E., Phillips M. Nutritional therapy in chronic pancreatitis // Gastroenterol. Clin. N. Am. 2018. Vol. 47. - 1. P. 95–106.

90..•., . ., • „ .•. € . ™ „ … •

„ // „ ,

. 2011. - 4. •. 18–25.

91..•., . ., ” •. . € . ™ „ „•• … …

… „

… // ™ . 2010. - 15. •. 98–104.

ACG-2020 Clinical Guidelines for the Diagnosis and Treatment of Chronic Pancreatitis:

Overview of Key Provisions in Practice

Yu.A. Kucheryavy, MD, PhD1, M.A. Kiryukova, MD2, Ye.A. Dubtsova, MD, PhD2, D.S. Bordin, MD, PhD, Prof.1–3

1A.I. Yevdokimov Moscow State University of Medicine and Dentistry

2A.S. Loginov Moscow Clinical Research and Practical Center

3Tver State Medical University

Contact person: Yury A. Kucheryavy, proped@mail.ru

In recent years, a number of international consensus documents and recommendations for the diagnosis and treatment of€chronic pancreatitis have been published: United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) in 2017, International Consensus Statements on Early Chronic Pancreatitis in 2018, American College of Gastroenterology Clinical Guideline on chronic pancreatitis in 2020. ˜e article analyzes the€main statements of these recommendations and the possibility of their adaptation to the Russian clinical practice.

Key words: chronic pancreatitis, external pancreatic insu™ciency, diagnosis, treatment, pancreatin preparations

View publication stats